Nyxoah Revenue and Competitors
Estimated Revenue & Valuation
- Nyxoah's estimated annual revenue is currently $43.7M per year.
- Nyxoah's estimated revenue per employee is $251,000
Employee Data
- Nyxoah has 174 Employees.
- Nyxoah grew their employee count by 4% last year.
Nyxoah's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, US Operations | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | VP Research And Development | Reveal Email/Phone |
5 | VP Marketing & Market Development | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | VP Operations | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Sr. Director Market Development | Reveal Email/Phone |
10 | Senior DIrector Training and Education US | Reveal Email/Phone |
Nyxoah Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Nyxoah?
Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah's team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah's innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide. Nyxoah therapy will offer: - Unparalleled clinical efficacy - Increased patient comfort, therapy compliance and quality of life - Minimally invasive approach, thus streamlining patient flow and reducing surgery related risks - Positive health economics outcomes by reducing the burden of OSA and its comorbidities
keywords:N/AN/A
Total Funding
174
Number of Employees
$43.7M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nyxoah News
Nyxoah logo Oppenheimer initiated coverage on shares of Nyxoah (NASDAQ:NYXH Get Rating) in a note issued to investors on Wednesday,...
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea...
Welcome to the Nyxoah full year 2021 earnings conference call. [Operator instructions] I would now like to hand the conference over to your...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $72M | 266 | 13% | N/A |
#2 | $138.7M | 451 | -1% | N/A |
#3 | $81.7M | 503 | -1% | N/A |